JPMorgan European Discovery

Closed Period Notification
RNS Number : 7986N
JPMorgan European Discovery Trust
01 October 2021






(the 'Company')


Compliance with Market Abuse Regulation



Legal Entity Identifier: 54930049CEWDI46Y3U28

Information disclosed in accordance with Market Abuse Regulation Article 19, paragraph 11


The Company announces that it is satisfied that any inside information which the Directors and the Company may have in the period leading up to the announcement of its results for the half year ended 30th September 2021 has previously been, and will continue to be, notified to the London Stock Exchange ('LSE') via a regulatory information service. Therefore the Company is not prohibited from dealing in its own securities.


The mandatory closed period under MAR will commence on 25th October 2021 and will expire when the results in respect of the half year ended 30th September 2021 are published, which is expected to be on or around 9th December 2021.      


If in the period leading up to the announcement of the annual results the Directors of the Company come into the possession of any inside information, this will be notified to the London Stock Exchange without delay and before any such transactions are undertaken.



JPMorgan Funds Limited - Company Secretary

1st October 2021



For further information, please contact:


Priyanka Vijay Anand

JPMorgan Funds Limited                                            

020 7742 4000




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.